These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6200 related articles for article (PubMed ID: 3356608)

  • 21. Development of new mitomycin C and porfiromycin analogues.
    Iyengar BS; Lin HJ; Cheng L; Remers WA; Bradner WT
    J Med Chem; 1981 Aug; 24(8):975-81. PubMed ID: 7328599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformations of complexes between mitomycins and decanucleotides. 3. Sequence specificity, binding at C-10, and mitomycin analogues.
    Remers WA; Rao SN; Wunz TP; Kollman PA
    J Med Chem; 1988 Aug; 31(8):1612-20. PubMed ID: 3397999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and biological activities of 10-decarbamoyloxy-9-dehydromitomycin B and its analogs.
    Urakawa C; Tsuchiya H; Nakano K; Nakamura N
    J Antibiot (Tokyo); 1981 Sep; 34(9):1152-6. PubMed ID: 7328056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitomycin C analogues with increased metal complexing ability.
    Iyengar BS; Sami SM; Takahashi T; Sikorski EE; Remers WA; Bradner WT
    J Med Chem; 1986 Sep; 29(9):1760-4. PubMed ID: 3091833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New potent mitomycin derivatives: synthesis and antitumor activity of 7,7-(ethylenedioxy)mitomycins.
    Kanda Y; Arai H; Ashizawa T; Morimoto M; Kasai M
    J Med Chem; 1992 Jul; 35(15):2781-6. PubMed ID: 1495011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
    Sato M; Onishi H; Takahara J; Machida Y; Nagai T
    Biol Pharm Bull; 1996 Sep; 19(9):1170-7. PubMed ID: 8889036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.
    Hodges JC; Remers WA; Bradner WT
    J Med Chem; 1981 Oct; 24(10):1184-91. PubMed ID: 7328580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitumor activity of novel mitomycin derivatives containing functional groups at the C-6-methyl position.
    Arai H; Kanda Y; Ashizawa T; Morimoto M; Gomi K; Kono M; Kasai M
    J Med Chem; 1994 Jun; 37(12):1794-804. PubMed ID: 8021918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antineoplastic activity of 1a-formyl and 1a-thioformyl derivatives of mitomycin C and 2-methylaziridine.
    Fishbein PL; Kohn H
    J Med Chem; 1987 Oct; 30(10):1767-73. PubMed ID: 3116255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function.
    Na Y; Wang S; Kohn H
    J Am Chem Soc; 2002 May; 124(17):4666-77. PubMed ID: 11971715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia.
    Iyengar BS; Dorr RT; Remers WA
    J Med Chem; 1991 Jul; 34(7):1947-51. PubMed ID: 1906107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.
    Ishizeki S; Ohtsuka M; Irinoda K; Kukita K; Nagaoka K; Nakashima T
    J Antibiot (Tokyo); 1987 Jan; 40(1):60-5. PubMed ID: 3104267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, DNA cross-linking activity, and cytotoxicity of dimeric mitomycins.
    Na Y; Li VS; Nakanishi Y; Bastow KF; Kohn H
    J Med Chem; 2001 Oct; 44(21):3453-62. PubMed ID: 11585450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular interaction and in vitro antitumor activity of lipophilic mitomycin C prodrugs.
    Matsumoto S; Hayashi Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3784-91. PubMed ID: 3124966
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative antitumor activities of 7-N-(p-hydroxyphenyl)mitomycin C (M-83) and mitomycin C.
    Imai R; Morimoto M
    J Antibiot (Tokyo); 1983 May; 36(5):559-65. PubMed ID: 6409871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of mitomycin C with synthetic polyribonucleotides containing guanine or guanine analogs.
    Weaver J; Tomasz M
    Biochim Biophys Acta; 1982 May; 697(2):252-4. PubMed ID: 6809051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structure-activity relationships of new dimeric mitomycin derivatives; 7-N,7'-N'-bis(omega-thioalkyl)dimitomycins.
    Kono M; Saitoh Y; Kasai M; Shirahata K; Morimoto M; Ashizawa T
    J Antibiot (Tokyo); 1993 Sep; 46(9):1428-38. PubMed ID: 8226321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of 9,10-unsaturation in the mitomycins: facile fragmentation of beta-alkyl-beta-aryl-alpha-oxo-gamma-butyrolactones.
    Ziegler FE; Berlin MY; Lee K; Looker AR
    Org Lett; 2000 Nov; 2(23):3619-21. PubMed ID: 11073659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 14-Fluoroanthracyclines. Novel syntheses and antitumor activity.
    Matsumoto T; Ohsaki M; Yamada K; Matsuda F; Terashima S
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):3793-804. PubMed ID: 3245970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 310.